Infosys Dividend 2026, Infosys Q4 Results 20256 date: As the earnings season is about to begin soon, BSE and NSE-listed companies have started announcing their schedule to declare earnings for Q4 FY26. Bengaluru-based IT giant is also all set to declare its earnings for the January-March period of the current financial year. Apart from the…
Sensex Prediction for Wednesday, March 18: Hitesh Tailor, Technical Research Analyst at Choice Equity Broking Private Limited, noted that the index is showing early signs of short-term stabilisation. However, he cautioned that for this uptrend to be sustainable, the market needs to see consistent follow-through buying. No stock data available The Indian stock markets witnessed…
Regulatory Compliance and Communication The announcement was communicated to both BSE Limited and National Stock Exchange of India Limited through reference number IGL/SE/2025-26/90 dated March 17, 2026. The communication was signed by Ankur Jain, Head (Legal) & Company Secretary, and has been hosted on the company’s official website at www.indiaglycols.com for stakeholder reference. Source link
Temasek, the Singaporean investment firm, holds a majority stake of just over 50 per cent in the company. The Ranjan Pai-controlled Manipal Group owns close to a 30 per cent stake. In 2024, Mubadala, the UAE sovereign wealth fund, along with investors including CalPERS, entered Manipal Health Enterprises, holding around a 10 per cent stake….
The company has fixed Monday, March 23, 2026 as the ‘Record Date‘ for the said dividend. Meanwhile, PFC informed the exchanges that the said dividend shall be paid to shareholders on or before April 16, 2026. Read Full Article “It is to inform that 23.03.2026 (Monday) shall be reckoned as the ‘Record Date’ for the…
Indian equity benchmark indices closed in the green territory today, March 17, extending gains from the previous session as investors increasingly hoped for the resumption of traffic through the Strait of Hormuz after prolonged closure. The 30-share BSE Sensex gained 567.99 points or 0.75 per cent to close at 76,070.84, while the NSE Nifty50 rose…
Turning to Paytm, Singh pointed out that the stock has already undergone a deep correction. “Paytm has corrected close to 40 per cent from its recent highs and is now consolidating,” he said. According to him, the stock is finding near‑term support around the 1,000 mark. “A bounce of about 8–10 per cent towards 1,080–1,100…
Despite the recent downturn in the consumer durable sector, which includes EMS-related stocks, the global investment bank believes that the long-term growth story for India’s EMS industry remains intact. This outlook is supported by government initiatives such as the Production Linked Incentive (PLI) scheme, improving supply chains, and rising domestic demand. Source link
The market regulator noted that mutual funds frequently encounter timing gaps between redemption payouts and the receipt of investment proceeds on settlement days. Typically, redemption payments to investors are processed in the morning of the T+1 settlement cycle, whereas funds from instruments such as TREPS and reverse repo transactions usually arrive later in the evening….
Pharma stocks including Ajanta Pharma, Sun Pharmaceutical Industries, and Lupin were buzzing in trade as investor focus sharpened ahead of Novo Nordisk A/S’s blockbuster weight‑loss drug semaglutide losing patent protection in India. The key patent for semaglutide, the active ingredient in Ozempic and Wegovy, which transformed the global weight‑loss and diabetes treatment landscape, is set…
